- Tweeting yourself out of a job: Do social media influencers need reputational risk insurance?
By Madeline Johnson | 20 April 2018
Individuals who rely on their name for income may have a need for some type of reputation risk or business interruption insurance, but could such a product exist?
- PRA’s Consultation Paper on modelling of the volatility adjustment for internal model firms
By Robert Bugg, Lyndsay Wrobel | 20 April 2018
The proposal to consider applications from internal model firms that include a Dynamic Volatility Adjustment is relevant to UK Solvency II firms and to the Society of Lloyd’s and its managing agents, and most relevant to firms with, or seeking, Volatility Adjustment approval and which use, or may develop in the future, a full or partial internal model to determine the Solvency Capital Requirement.
- How changing opioid prescribing patterns can impact risk scores
By Christine M. Mytelka, Melanie K. Kuester, Colin R. Gray, Lucas Everheart | 19 April 2018
This brief provides data on the decline in opioids prescribed to Medicaid expansion populations and the increased use of other non-opioid pain relief drugs.
- 2018 Corporate Pension Funding Study
By Zorast Wadia, Alan H. Perry, Charles J. Clark | 18 April 2018
During 2017, the private single-employer defined benefit plans of the Milliman 100 companies made significant funding improvements.
- Brexit: Beyond passporting: Implications for the UK insurance industry
By Kyle Audley, Jennifer Strickland, Fred Vosvenieks | 18 April 2018
This paper considers various future routes that the development of insurance regulation in the UK could take due to Brexit and the impact each of these might have on UK insurers.
- A “gold standard” for population health? Revisiting the FDA’s relationship with the Hippocratic Oath
By Gillian Woollett, Bruce S. Pyenson | 16 April 2018
The Food and Drug Administration should use a population health context to meet 21st century expectations for pharmaceutical risk.
- The exclusion of some nursing facility visits from MSSP assignment has potential unintended consequences
By Tia Goss Sawhney, Kathryn V. Fitch, Cory Gusland | 16 April 2018
This article describes the changes in the historical benchmarks and performance expenditures for a number of Medicare Shared Savings Program accountable care organizations and also explains the possible impact of these changes.
- Market commentary, 1st Quarter 2018
13 April 2018
Markets showed signs of volatility as investors feared an uptick in both global protectionism and inflation expectations.
- Borderland controls
By Jennifer Strickland, Kyle Audley | 13 April 2018
Brexit is likely to have a large impact on the insurance industry, and the approach taken towards Solvency II in particular will be a key determinant of the future of UK insurance regulation.
- Analysis of Dutch insurers’ Solvency and Financial Condition Reports in European context
By Simon Cureton, Peter Franken, Judith Houtepen, Kamiel van Langen, Kendall Carolissen, Moussa M Ouédraogo | 12 April 2018
This report provides a summary of the key solvency information of the main life and non-life insurance entities in the Netherlands based on the Solvency and Financial Condition Reports published in May 2017.